Treatment of Complete or Bilateral Abducens Nerve Palsy with No Lateral Rectus Function
This protocol addresses the management of complete abducens nerve palsy — where the lateral rectus muscle is non-functional and the eye cannot abduct beyond the midline — as well as bilateral abducens nerve palsy, presentations in which spontaneous recovery rates are relatively low.
Clinical Scenario
In complete abducens nerve palsy, there is no function in the lateral rectus and the eye cannot abduct beyond the midline. During the acute phase, classification of partial versus complete palsy is based primarily on whether abduction can pass the midline. Bilateral involvement is an additional distinct presentation covered by this protocol.
Management Overview (partial — full regimen below)
The first priority is identifying and treating the underlying cause. During the acute phase, occlusion-based approaches and optical correction are used to relieve diplopia. For complete or bilateral presentations, early targeted intervention within the first months of onset may be considered — the complete structured protocol, including all available options and their sequencing, is accessible via the link below.
Clinical Goals
Reduction of esotropia and relief of diplopia, with improved binocular function.
References
DOI: 10.1016/j.apjo.2026.100297
- In complete abducens nerve palsy, there is no function in the lateral rectus, and the eye cannot abduct beyond the midline.
- During the acute phase, classification of partial versus complete palsy is primarily based on whether abduction can pass the midline.
- Early botulinum toxin injection into the ipsilateral medial rectus (within 1–3 months) may be considered in complete or bilateral abducens nerve palsies, in which spontaneous recovery rates are relatively low.
- The first priority is always to treat the underlying causes.
- During the acute phase, patching, opaque lenses, or prisms are recommended to relieve diplopia.
- By inducing temporary chemodenervation of the ipsilateral medial rectus, it improves agonist-antagonist balance, reduces esotropia, enhances binocularity, and prevents contracture.
- Early injection may improve binocular function more quickly, thereby alleviating diplopia while awaiting recovery or surgery.
View source ↗